The global CAR T-cell therapy market is experiencing remarkable growth, driven by increasing demand for innovative cancer treatment options. This rapid expansion is fueled by factors such as the acceptance of CAR T-cell therapies for various indications, advancements in production technologies, and expanding research and development initiatives. F